Products
Online Inquiry
Caffeic acid
Cat. No.:
0225LY-1255
Purity:
≥99%
Identity:
Confirmed by NMR, and HPLC.
Size:
Add to basket
Product Overview
Description:
Caffeic acid is a polyphenol and hydroxycinnamic acid derivative that is orally bioavailable, offering potential antineoplastic, anti-inflammatory, and antioxidant benefits.
Synonym:
3,4-Dihydroxycinnamic acid; 331-39-5; Trans-caffeic acid; 3-(3,4-dihydroxyphenyl)acrylic acid; 3,4-Dihydroxybenzeneacrylic acid; (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; 3-(3,4-Dihydroxyphenyl)-2-propenoic acid; (E)-3-(3,4-dihydroxyphenyl)acrylic acid; (E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; Caffeicacid; Cinnamic acid, 3,4-dihydroxy-; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-; 4-(2-Carboxyethenyl)-1,2-dihydroxybenzene; Trans-Caffeate; 3,4-Dihydroxy-trans-cinnamate; 3-(3,4-Dihydroxyphenyl)propenoic acid; 4-(2'-Carboxyvinyl)-1,2-dihydroxybenzene; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, (E)-
CAS No.:
331-39-5
Compound CID:
689043
Formula:
C9H8O4
Formula Weight:
180.16
Specification
Relative Density:
1.2933 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Caffeic acid can be used in antioxidant research or play a significant role in studies concerning the inhibition of lipid peroxidation and inflammation.
Library Information
Target:
Lipoxygenase; TRP/TRPV channel
Receptor:
5-Lipoxygenase; hTRPA1; Lipoxygenase; TRP channel
Pathways:
Membrane transporter/Ion channel; Metabolism
Plate Number:
AOCL-17
Plate Location:
b2
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
250 mg/mL; 1387.66 mM
Water Max Solubility:
<1 mg/mL (insoluble or slightly soluble)
Ethanol Max Solubility:
<1 mg/mL (insoluble or slightly soluble)
